Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Principal Healthcare Innovators Index (BTEC)

Principal Healthcare Innovators Index (BTEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Principal Financial Group
  • Assets Under Management 109,951,000
  • Market Capitalization, $K 109,951
  • Shares Outstanding, K 2,150
  • 60-Month Beta 1.37
Trade BTEC with:
  • Price/Earnings ttm 18.97
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.42%
  • Sectors:

    ETFs - Large Cap

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.71 +12.73%
on 09/24/20
52.50 -4.00%
on 10/12/20
+2.65 (+5.55%)
since 09/18/20
3-Month
40.84 +23.41%
on 09/04/20
52.50 -4.00%
on 10/12/20
+2.58 (+5.39%)
since 07/17/20
52-Week
25.34 +98.90%
on 03/18/20
52.50 -4.00%
on 10/12/20
+18.77 (+59.32%)
since 10/18/19

Most Recent Stories

More News
Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

AZN : 52.44 (-1.11%)
PFE : 37.80 (-0.40%)
GILD : 60.57 (-2.31%)
IMMU : 87.61 (+0.06%)
MRNS : 15.08 (+1.07%)
PTH : 144.26 (-1.13%)
WVE : 8.41 (-5.72%)
BBC : 41.72 (-2.80%)
BTEC : 50.40 (-1.83%)
NVUS : 17.26 (+1.23%)
SAVA : 9.84 (-6.11%)
IDNA : 40.68 (-1.86%)
IBBJ : 28.26 (-1.57%)
4 Best-Performing Sector ETFs of Last Week

The S&P 500, the Dow Jones and the Nasdaq Composite have lost about 0.6%, 0.03% and 0.6%, respectively, past week.

AZN : 52.44 (-1.11%)
CZR : 53.42 (-2.82%)
LIT : 41.54 (-1.26%)
BTEC : 50.40 (-1.83%)
DKNG : 44.58 (+0.54%)
BETZ : 21.43 (-2.32%)
IBBJ : 28.26 (-1.57%)
Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

MRNA : 70.96 (-4.03%)
IBB : 137.43 (-1.63%)
CNCR : 28.74 (-2.74%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
BTEC : 50.40 (-1.83%)
IDNA : 40.68 (-1.86%)
GERM : 29.08 (-2.12%)
Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

BBC : 41.72 (-2.80%)
BTEC : 50.40 (-1.83%)
IDNA : 40.68 (-1.86%)
IBBJ : 28.26 (-1.57%)
Moderna ETFs to Shine on U.S. Contracts for Coronavirus Vaccine

Moderna has inked a $1.5-billion coronavirus vaccine supply agreement with the U.S. government.

MRNA : 70.96 (-4.03%)
IBB : 137.43 (-1.63%)
CNCR : 28.74 (-2.74%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
BTEC : 50.40 (-1.83%)
IDNA : 40.68 (-1.86%)
GERM : 29.08 (-2.12%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 52.44 (-1.11%)
MRNA : 70.96 (-4.03%)
GSK : 36.18 (-1.07%)
NVAX : 102.05 (-4.66%)
CNCR : 28.74 (-2.74%)
INO : 11.35 (-4.22%)
PTH : 144.26 (-1.13%)
BBC : 41.72 (-2.80%)
BTEC : 50.40 (-1.83%)
ARKG : 73.27 (-0.56%)
IDN : 7.05 (-0.56%)
VXRT : 5.67 (-6.74%)
GNOM : 19.29 (-0.41%)
5 Top-Performing ETF Areas of April That Are Up At Least 25%

These ETF areas showered gains in the lockdown-infected April.

GILD : 60.57 (-2.31%)
AMLP : 21.44 (-1.61%)
XBI : 118.29 (-1.93%)
SGDM : 33.38 (-1.91%)
AMZA : 14.65 (-1.94%)
FCG : 6.37 (-1.70%)
RING : 32.69 (-1.42%)
IBUY : 96.52 (-0.64%)
MLPA : 23.50 (-1.34%)
GOEX : 36.19 (-1.09%)
BTEC : 50.40 (-1.83%)
AMU : 7.30 (-1.48%)
GOAU : 22.28 (-1.89%)
ON : 26.21 (+0.54%)
5 High-Beta ETFs Available at a Bargain

As the U.S. economy reopens, Wall Street may remain charged up, benefiting high-beta ETFs. Investors can tap those with cheaper valuation.

SPY : 342.01 (-1.52%)
XHB : 56.19 (-1.97%)
XRT : 53.68 (-1.11%)
XTH : 71.14 (-0.18%)
RFV : 59.66 (-1.27%)
SPHB : 43.36 (-0.98%)
BTEC : 50.40 (-1.83%)
A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

SBIO : 44.12 (-1.80%)
BBP : 49.65 (-1.51%)
BTEC : 50.40 (-1.83%)
BBH : 160.30 (-1.75%)
XBI : 118.29 (-1.93%)
IBB : 137.43 (-1.63%)
FBT : 157.99 (-1.64%)
CNCR : 28.74 (-2.74%)
PBE : 60.94 (-0.85%)
ARKG : 73.27 (-0.56%)
Top-Performing Biotech ETFs YTD

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

RHHBY : 42.3600 (-0.33%)
BMY : 60.77 (-0.77%)
XBI : 118.29 (-1.93%)
BTEC : 50.40 (-1.83%)
BBH : 160.30 (-1.75%)
SBIO : 44.12 (-1.80%)
ILMN : 321.26 (-1.55%)
CELG : 108.24 (+0.10%)
GILD : 60.57 (-2.31%)
GLPG : 130.40 (+1.22%)
AMGN : 230.71 (-2.13%)
EC : 9.71 (+0.52%)
ARKG : 73.27 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Principal Healthcare Innovators Index ETF seeks to provide investment results that closely correspond, before expenses, to the performance of the NASDAQ U.S. Healthcare Innovators Index. The ETF employs a passive investment approach designed to track the performance of the Index.

See More

Key Turning Points

2nd Resistance Point 52.00
1st Resistance Point 51.20
Last Price 50.40
1st Support Level 49.94
2nd Support Level 49.47

See More

52-Week High 52.50
Last Price 50.40
Fibonacci 61.8% 42.12
Fibonacci 50% 38.92
Fibonacci 38.2% 35.72
52-Week Low 25.34

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar